Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 12, 2026 09:29 ET | Source: Cosmos Health Inc.

Cosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross Profit

Cosmos Health announces strong sales momentum for its proprietary antiseptic brands, C-Scrub and C-Sept.
June 10, 2026 15:32 ET | Source: Cosmos Health Inc.

Cosmos Health Signs 3-Year Contract Manufacturing Agreement with Verisfield for 3.9 Million Units of VASCLOR GEST Progesterone Pessaries

Cosmos Health secures a 3-year contract manufacturing agreement for 3.9 million units of VASCLOR GEST progesterone pessaries.
June 10, 2026 09:00 ET | Source: Cosmos Health Inc.

Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform — Record Growth with U.S. Expansion Underway

Cosmos Health CEO issues letter to shareholders.
June 09, 2026 15:30 ET | Source: Cosmos Health Inc.

Cosmos Health Inaugurates State-of-the-Art Capsule Production Line with New 5-Year Contract Manufacturing Agreement with Provident Pharmaceuticals for 385,000 Units of CERTORUN

Cosmos Health inaugurates state-of-the-art capsule production line and secures new 5-year contract manufacturing agreement for 385,000 units
June 04, 2026 09:25 ET | Source: Cosmos Health Inc.

Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value

Cosmos Health identifies approximately $20 million in non-core assets available for monetization to accelerate growth and unlock shareholder value.
June 02, 2026 08:00 ET | Source: Cosmos Health Inc.

Cosmos Health Provides Balance Sheet Update: Highlights European Investment Bank Financing Discussions for up to €25M, Eliminates 38% of Warrant Overhang with No Dilution; Reaffirms Growth Trajectory; Notes No Known Business Reason for Recent Share Price Decline

Cosmos Health provides balance sheet update and notes no known business reason for reason for recent share price decline. Reaffirms growth outlook.
June 01, 2026 08:25 ET | Source: Cosmos Health Inc.

Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657

Cosmos Health enters the animal health market, extending the C-Scrub brand into the veterinary space following successful European standard testing.
May 26, 2026 09:34 ET | Source: Cosmos Health Inc.

Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted EBITDA by 2029 — Building an Innovative, High-Margin Healthcare Platform with Strong Cash Generation

Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted EBITDA by 2029.
February 19, 2026 11:30 ET | Source: Cosmos Health Inc.

Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value

The estimated fair market value of the Company’s real estate assets is approx $15 million, exceeding the current market cap of approx $13.5 million.
February 17, 2026 11:25 ET | Source: Cosmos Health Inc.

Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026

CHICAGO, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced its...